FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention provides new imidazo[1,2-b]pyridazine compounds covered by general structural formula (I) 
wherein the radicals and symbols have the values presented in the patent claim, and pharmaceutically acceptable salts thereof. The compounds of structural formula (I) are effective both for treating or preventing the diseases related to GABA receptor inhibition, anxiety, epilepsy, sleep disorders, including insomnia, and for inducing a sedative-hypnotic, anaesthetic effect, sleep and muscle relaxation.
EFFECT: there are presented methods for preparing the above compounds, and also intermediate compounds for preparing them.
21 cl, 4 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AS KINASE INHIBITORS | 2013 |
|
RU2635917C2 |
| 2-ARYLIMIDAZO[1,2-b]PYRIDAZINE,2-PHENYLIMIDAZO[1,2-a]PYRIDINE AND 2-PHENYLIMIDAZO[1,2-a]PYRAZINE DERIVATIVES | 2011 |
|
RU2598385C2 |
| SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS AND THEIR USE FOR TREATMENT OF PATHOLOGICAL CONDITIONS | 2017 |
|
RU2773333C2 |
| METHOD OF SYNTHESIS OF IMIDAZO-(1,2-B)-PYRIDAZINE OR THEIR SALTS AND IMIDAZO-(1,2-B)-PYRIDAZINE DERIVATIVES OR THEIR SALTS | 1990 |
|
RU2036924C1 |
| METHOD OF SYNTHESIS OF COMPOUNDS OF GROUP IMIDAZO-[1,2-B]-PYRIDAZINE OR THEIR SALT | 1991 |
|
RU2034846C1 |
| IMIDAZO[1,2-b]PYRIDAZINE AND PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND USE THEREOF AS PROTEIN KINASE INHIBITOR | 2007 |
|
RU2487875C2 |
| ARYL-ISOXAZOL-4-YL-IMIDAZO[1,2-a]PYRIDINE SUITABLE FOR TREATING ALZHEIMER'S DISEASE THROUGH GABA RECEPTORS | 2007 |
|
RU2426732C2 |
| SUBSTITUTED IMIDAZOPYRIDINYL-AMINO-PYRIDINE COMPOUNDS, USEFUL FOR TREATMENT OF CANCER | 2010 |
|
RU2619463C2 |
| TRIAZOLOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION AND USE THEREOF AS MEDICINAL AGENTS | 2009 |
|
RU2499797C2 |
| 2-PHENYLIMIDAZO[1,2-A]PYRIMIDINES AS IMAGING AGENTS | 2014 |
|
RU2665580C2 |
